DoW Toxic Exposures Clinical Trial Award
Department of War (Defense Health Agency) Toxic Exposures Research Program Clinical Trial Award funding clinical trials, from small proof-of-concept through large-scale, addressing conditions tied …
- Deadline
- Nov 19, 2026
- Posted
- May 21, 2026
- Award amount
- Amount not specified
Don’t miss this deadline
We’ll email you before Nov 19, 2026 so you have time to apply.
In plain English
Department of War (Defense Health Agency) Toxic Exposures Research Program Clinical Trial Award funding clinical trials, from small proof-of-concept through large-scale, addressing conditions tied to military-related toxic exposures. Eligibility is listed as unrestricted/open to any entity type subject to clarification in the full notice; a partnering principal investigator option supports two-PI collaborations. No award amount is specified. The stated eligibility is broad, but applicants need the capacity to run clinical trials.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Who can apply
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
About this grant
Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations. Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO) . One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts. https://cdmrp.health.mil/pubs/press/2026/terppreann
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants funding Science and Technology and other Research and Development — soonest deadline first.
DoW Lupus, Transformative Vision Award
Defense Health Agency Contracting Activity - DHACA · Amount varies · Due in 3 days
DoW Lupus, Idea Award
Defense Health Agency Contracting Activity - DHACA · Amount varies · Due in 3 days
DoW Lupus, Impact Award
Defense Health Agency Contracting Activity - DHACA · Amount varies · Due in 3 days
DoW Lupus, Transformative Vision Development Award
Defense Health Agency Contracting Activity - DHACA · Amount varies · Due in 3 days
DoW Prostate Cancer, Physician Research Award
Defense Health Agency Contracting Activity - DHACA · Amount varies · Due in 12 days
DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award
Defense Health Agency Contracting Activity - DHACA · Amount varies · Due in 12 days
Also listed under Defense Health Agency Contracting Activity - DHACA and Science & Research Grants.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.